|Working Paper 154||Final “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 31/08/2021)|
|Working Paper 152||
“All offices” experience of term assurances for 2015-2018 and 2019 plus indicative analysis of experience to mid-2020 (Issue date: 29/06/2021)
|Working Paper 151||
Accelerated critical illness experience by cause of claim, 2015-2018 (Issue Date: 11/06/2021)
|Working Paper 150||Proposed “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 30/04/2021; Response date: 30/06/2021)|
|Working Paper 132||“All offices” experience of term assurances, 2015-2018 (Issue date: 07/05/2020; v02 issue date: 29/04/2021; v03 issue date: 29/06/2021)|
|Working Paper 125||Additional analysis of the experience of term assurances, 2011-2016 (Issue date: 15/11/2019)|
|Working Paper 123||
"All offices” experience of term assurances, 2011-2016 (v01: issue date: 18/07/2019; v02 issue date: 07/05/2020)
|Working Paper 110||Working Paper 110: Using the CMI Mortality Projections Model for assured lives (Issue date: 04/10/2018; Response date: 31/12/2018)|
|Working Paper 108||Interim “all offices” experience of term assurances, 2011-2015 (v01 issue date: 08/06/2018; v02 issue date: 07/05/2020; Response date: 12/07/2018)|
|Working Paper 94||Final "08" Series accelerated critical illness and term mortality tables (Issue date: 27/01/2017)|
|Working Paper 92||Proposed "08" Series term mortality tables (Issue Date: 07/10/2016; Response date: 30/11/2016)|
|Proposed "08" Series accelerated critical illness tables (Issue date: 06/05/2016; Reissued: 07/10/2016; Response date: 30/11/2016)|
|All-Offices Mortality and Critical Illness Experience for the 2007-2010 Quadrennium (Issue date: 03/12/2014; Reissued: 01/02/2016)|
|A revised approach for analysing CMI critical illness experience and restated results for accelerated business, 2003-2006 (Issue date: 10/05/2013)|
|Supplementary analyses to CMI critical illness diagnosis rates for accelerated business, 2003-2006|
|Cause-specific CMI critical illness diagnosis rates for accelerated business, 2003-2006 (Issue date: 15/06/2011)|
|CMI critical illness diagnosis rates for accelerated business 2003-2006 (Issue date: 24/01/2011)|
|CMI critical illness diagnosis rates for accelerated business 1999-2004 (Issue date: 12/02/2010)|
|The mortality of impaired assured lives: Report on 1995-2006 experience and consultation on the future of the investigation (Issue date: 14/01/2009)|
|A new methodology for analysing CMI critical illness experience (Issue date: 23/07/2008)|
|Progress towards an improved methodology for analysing CMI critical illness experience (Issue date: 27/07/2007)|
|1999-2002 critical illness experience: feedback on Working paper 14 and future work (Issue date: 01/12/2005)|
|Methodology underlying the 1999-2002 CMI critical illness experience investigation (Issue date: 05/05/2005)|
|The graduation of the CMI 1999-2002 mortality experience: feedback on Working paper 8 and proposed assured lives graduations (Issue date: 11/04/2005)|
If you have any questions about the CMI please email
Filter or search events
We’ve all heard about the gender pay gap. Sadly, the gap doesn’t just exist with base pay.
Research carried out by Legal & General in 2021 across the four million members in our Defined Contribution (DC) pensions, found that there’s a gender pension gap too, continuing the divide between men and women.
As current global events continue to demonstrate, geopolitical tensions present significant risks to corporates of all sizes. However, these types of risk are often not given the discussion time it needs at the board level or executive committee levels, nor the resources required to anticipate, analyse and mitigate them effectively.
At retirement, it has become very popular for those with Defined Contribution (DC) pensions to choose drawdown rather than an annuity, but drawing a sustainable lifetime income in this way is an impossible challenge for most people. We consider a Decumulation Pathway for the typical consumer, where a small part of the DC fund is set aside for any flexible access and legacy requirements. The bulk is then used to provide a lifetime income, utilising the pooling or insuring of longevity risk.
We continue to live in a world of global uncertainty. Survival depends on our ability to simultaneously navigate through the diverse root-causes, ranging from: the consequences of Climate Change; transitioning to Net Zero; increased inflationary pressures and supply chain issues; to self-imposed changes in regulatory requirements. CILA 2022 focuses on these challenges to ensure we continue to be informed and remain battle ready, as well as showcasing highlights of recent CMI outputs.
In the spirit of fostering the IFoA’s vibrant, global community and enabling our members to participate, we have decided to hold our AGM virtually again this year. This allows for greater accessibility to this important annual event, and for greater accountability of our organisation.
The Business of the AGM
Join newly inaugurated IFoA President, Matt Saker, for his Presidential Address.
We’re delighted to welcome you back to our first in-person conference since early 2020, also being delivered virtually in our first-ever hybrid event. The theme of our inaugural two-day conference is ‘Focusing on tomorrow’s actuary’ and will explore the contribution actuarial science is making to some of tomorrow’s biggest issues.